Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HGF | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | EML5 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | LXN | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | CLUL1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | C2orf66 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | ZNF621 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | TNS2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | EMC4 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | LYSMD4 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | CDR2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |